ZA963694B - Methods for inhibiting bone loss. - Google Patents

Methods for inhibiting bone loss.

Info

Publication number
ZA963694B
ZA963694B ZA9603694A ZA963694A ZA963694B ZA 963694 B ZA963694 B ZA 963694B ZA 9603694 A ZA9603694 A ZA 9603694A ZA 963694 A ZA963694 A ZA 963694A ZA 963694 B ZA963694 B ZA 963694B
Authority
ZA
South Africa
Prior art keywords
methods
bone loss
inhibiting bone
inhibiting
loss
Prior art date
Application number
ZA9603694A
Other languages
English (en)
Inventor
James Edmund Audia
Blake Lee Neubauer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA963694B publication Critical patent/ZA963694B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9603694A 1995-05-10 1996-05-09 Methods for inhibiting bone loss. ZA963694B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/438,420 US5550134A (en) 1995-05-10 1995-05-10 Methods for inhibiting bone loss

Publications (1)

Publication Number Publication Date
ZA963694B true ZA963694B (en) 1997-11-10

Family

ID=23740592

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603694A ZA963694B (en) 1995-05-10 1996-05-09 Methods for inhibiting bone loss.

Country Status (10)

Country Link
US (2) US5550134A (de)
EP (1) EP0742010A3 (de)
JP (1) JPH11511739A (de)
AU (1) AU5855796A (de)
CA (1) CA2220034A1 (de)
IL (1) IL118196A (de)
MY (1) MY132322A (de)
WO (1) WO1996035422A1 (de)
YU (1) YU27296A (de)
ZA (1) ZA963694B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048694A1 (en) * 1996-06-20 1997-12-24 Board Of Regents, The University Of Texas System Compounds and methods for providing pharmacologically active preparations and uses thereof
US6111110A (en) * 1996-10-30 2000-08-29 Eli Lilly And Company Synthesis of benzo[f]quinolinones
ID21978A (id) * 1996-10-30 1999-08-19 Lilly Co Eli Sintesa benzo (f) kinolinon
ES2246501T3 (es) * 1996-11-29 2006-02-16 Basf Aktiengesellschaft Preparados cosmeticos y farmaceuticos que contienen filtros uv-a fotoestables.
AU5594398A (en) * 1996-12-09 1998-07-03 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss
US5945412A (en) * 1996-12-09 1999-08-31 Merck & Co., Inc. Methods and compositions for preventing and treating bone loss
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
SE9702401D0 (sv) * 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
WO1999007682A1 (en) * 1997-08-08 1999-02-18 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
GB9717428D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
US6096781A (en) 1997-11-14 2000-08-01 Eli Lilly And Company 2-arylbenzo[B]thiophenes useful for the treatment of estrogen deprivation syndrome
KR100261139B1 (ko) * 1998-01-16 2000-08-01 황준수 신규한 알릴티오피리다진 유도체 및 그의 제조방법
EP1089990A1 (de) * 1998-06-30 2001-04-11 Neurogen Corporation 1(benzothiazol-2-yl)-4-(phenylmethyl)piperazine: dopaminrezeptor subtyp spezifischer liganden
US6291463B1 (en) 1998-06-30 2001-09-18 Neurogen Corporation 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands
US6048869A (en) * 1998-07-29 2000-04-11 Merck & Co., Inc. Tricyclic compounds
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
US6258826B1 (en) 1998-10-13 2001-07-10 Eli Lilly And Company Pharmaceutical formulations and applications thereof for the treatment of estrogen deprivation syndrome
AU5250400A (en) * 1999-06-18 2001-01-09 Mitsubishi Pharma Corporation Osteogenesis promoters
WO2001017562A1 (fr) * 1999-09-02 2001-03-15 Yamanouchi Pharmaceutical Co., Ltd. Agents promoteurs de l'osteogenese
US20050124537A1 (en) * 2000-04-27 2005-06-09 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) * 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
AU2002211629A1 (en) * 2000-10-10 2002-04-22 Microchips, Inc. Microchip reservoir devices using wireless transmission of power and data
US7402577B2 (en) * 2001-10-03 2008-07-22 Merck & Co., Inc. Androstane 17-beta-carboxamides as androgen receptor modulators
AU2003219656B2 (en) 2002-01-15 2007-05-17 Merck Sharp & Dohme Corp. 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
US7045652B2 (en) * 2002-07-03 2006-05-16 Pfizer Inc Processes for preparing substituted aryl boronic acids
AU2003278766A1 (en) * 2002-09-04 2004-03-29 Microchips, Inc. Method and device for the controlled delivery of parathyroid hormone
GB0222516D0 (en) * 2002-09-27 2002-11-06 Karobio Ab Novel compounds
GB0319150D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
WO2005099707A1 (en) * 2004-04-08 2005-10-27 Merck & Co., Inc. 17 beta-acetamide-4-azasteroids as androgen receptor modulators
JP5007427B2 (ja) * 2004-05-13 2012-08-22 アルザ コーポレイション 副甲状腺ホルモン剤の経皮送達のための装置および方法
US20080076975A1 (en) * 2005-01-25 2008-03-27 Microchips, Inc. Method and implantable device with reservoir array for pre-clinical in vivo testing
CA2595457A1 (en) 2005-01-25 2006-08-03 Microchips, Inc. Control of drug release by transient modification of local microenvironments
FI3345607T3 (fi) 2006-12-29 2022-11-30 Menetelmiä luun kasvun muuttamiseksi antamalla SOST- tai WISE-antagonistia tai antagonistia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4351833A (en) * 1980-07-28 1982-09-28 Pfizer Inc. 9-Amino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof as analgesics and anti-emetics
US5239075A (en) * 1991-08-21 1993-08-24 Eli Lilly And Company Process for the preparation of benzo (f) quinolinones
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
TW450809B (en) * 1995-03-21 2001-08-21 Lilly Co Eli Pharmaceutical compositions for preventing or treating prostatic cancer comprising benzoquinolin-3-one derivatives

Also Published As

Publication number Publication date
IL118196A (en) 2000-06-29
WO1996035422A1 (en) 1996-11-14
JPH11511739A (ja) 1999-10-12
MY132322A (en) 2007-10-31
YU27296A (sh) 1999-07-28
US5670514A (en) 1997-09-23
US5550134A (en) 1996-08-27
EP0742010A3 (de) 2000-10-11
AU5855796A (en) 1996-11-29
EP0742010A2 (de) 1996-11-13
IL118196A0 (en) 1996-09-12
CA2220034A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
IL118196A0 (en) Methods for inhibiting bone loss
PH31315A (en) Methods for inhibiting bone loss using substitutedbenzothiophene.
ZA961316B (en) Benzopyran-containing compounds and method for their use.
MX213417B (es) Fenilpiridazinonas.
ZA961955B (en) Indazolecarboxamides.
ZA964778B (en) Methods for minimizing bone loss.
DE69610844D1 (en) Hydroformylierungsverfahren.
AU5743396A (en) Methods for inhibiting bone loss
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
AU5743696A (en) Methods for inhibiting bone loss
ZA964681B (en) Methods for minimizing bone loss.
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
ZA9610458B (en) Novel method.
ZA966750B (en) Halogenobenzimidazoles.
GB2308509B (en) Services-connections for trailer-vehicles
GB2308393B (en) Windshelter for sun-bathing
ZA969560B (en) Substituted 1-methyl-3-phenylpyrazoles.
GB2298174B (en) Services-connections for trailer-vehicles
ZA968953B (en) 24-homo-26,27-hexafluoro-cholecalciferols
ZA966114B (en) Scatterpile pusher.
GR2001758Y (en) Quick adding method.
ZA962751B (en) Ascomycins.
GB9507737D0 (en) Timbertech i.g.f. system
GR2001743Y (en) Recreational-gymnastic apparatus.
SI0874814T1 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols